M.D. Ph.D. Craig B. Granowitz - 02 Aug 2021 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Chief Medical Officer
Signature
/s/ Craig B. Granowitz, M.D., Ph.D.
Issuer symbol
LXRX
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 16:39:28 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 02 Aug 2021 Common Stock 250,000 $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (8/2/2022) and vests 1/48th per month for each month of service thereafter.